Nursing facility
Sierra Nevada Memorial-Miners Hospital
Sierra Nevada Memorial-Miners Hospital was paid $22.97M by Medicaid between Jan 2018 and Nov 2024, across 179 billing codes. Its largest line is 0450, Emergency room services — 34% of everything it billed.
33Billing provider infoSIERRA NEVADA MEMORIAL-MINERS HOSPITAL
GRASS VALLEY, CA 95945
GRASS VALLEY, CA 95945
33aNPI1659361392assigned 10/25/2005
33bProvider typeSkilled Nursing Facility
28Total paid$22.97M
24GClaims373,555
24DCodes billed179
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Skilled Nursing Facility providers in California
Rank by total paid#7 of 547
Median peer was paid$73K
This provider vs. median314×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,866 | $2.88M | |
| 2019 | 56,524 | $3.69M | |
| 2020 | 45,179 | $2.75M | |
| 2021 | 54,978 | $3.11M | |
| 2022 | 51,998 | $2.94M | |
| 2023 | 65,205 | $3.79M | |
| 2024incomplete | 44,805 | $3.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 34% | 34,899 | 30,442 | $7.80M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 8.6% | 10,323 | 8,985 | $1.97M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.7% | 6,726 | 5,822 | $1.30M |
| A9150 | Non-prescription drugs | 5.5% | 13,082 | 5,826 | $1.25M |
| 99199 | Unlisted special service, procedure or report | 4.3% | 13,127 | 10,825 | $982K |
| 36415 | Collection of venous blood by venipuncture | 4.3% | 9,808 | 8,203 | $977K |
| J3490 | Unclassified drugs | 2.7% | 10,646 | 5,351 | $625K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 2.6% | 4,916 | 2,796 | $591K |
| A0425 | Ground mileage, per statute mile | 2.1% | 13,132 | 10,883 | $476K |
| 0949 | 1.8% | 1,937 | 1,529 | $412K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 2,417 | 2,359 | $407K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 1.8% | 2,462 | 2,187 | $405K |
167 more codes
| 99283 | Emergency room visit (moderate) | 1.7% | 2,655 | $393K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 3,246 | $267K |
| 0250 | 1.2% | 18,399 | $267K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 3,626 | $254K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 1,334 | $251K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 6,619 | $250K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 2,728 | $242K |
| 99284 | Emergency room visit (serious) | 1.0% | 1,114 | $230K |
| 80053 | Comprehensive metabolic panel | <1% | 19,039 | $200K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,649 | $157K |
| 0762 | <1% | 130 | $151K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 764 | $150K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,955 | $115K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,756 | $113K |
| 73610 | <1% | 1,642 | $109K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 292 | $98K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 679 | $95K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,303 | $95K |
| 73630 | <1% | 1,718 | $92K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,085 | $92K |
| 73030 | <1% | 1,429 | $89K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,094 | $83K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 5,200 | $83K |
| G0378 | Hospital observation service, per hour | <1% | 1,626 | $83K |
| 73110 | <1% | 1,288 | $80K | |
| 73130 | <1% | 1,236 | $78K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,333 | $77K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 643 | $75K |
| Z7502 | <1% | 1,931 | $74K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,942 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,534 | $59K |
| 73562 | <1% | 999 | $57K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,309 | $57K |
| 87081 | <1% | 1,250 | $54K | |
| 76830 | Ultrasound, transvaginal | <1% | 580 | $53K |
| 81001 | <1% | 7,733 | $49K | |
| 81003 | <1% | 5,372 | $46K | |
| 93971 | <1% | 448 | $43K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 606 | $42K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,719 | $41K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 881 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,925 | $38K |
| 0510 | <1% | 893 | $36K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 513 | $36K |
| 72100 | <1% | 465 | $30K | |
| 73502 | <1% | 489 | $27K | |
| 87077 | <1% | 1,158 | $25K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 44 | $23K |
| 99285 | Emergency room visit (most serious) | <1% | 292 | $22K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 119 | $22K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 978 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,461 | $19K |
| 87631 | <1% | 578 | $18K | |
| T5999 | Supply, not otherwise specified | <1% | 122 | $18K |
| 73564 | <1% | 214 | $17K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 499 | $17K |
| 29125 | <1% | 157 | $16K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 189 | $16K |
| 12001 | <1% | 94 | $15K | |
| 73080 | <1% | 187 | $15K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 350 | $14K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 122 | $14K |
| 73140 | <1% | 246 | $14K | |
| 82962 | <1% | 1,480 | $13K | |
| 73221 | <1% | 15 | $13K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,453 | $13K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,436 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,452 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 173 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,669 | $11K |
| 83605 | <1% | 2,540 | $10K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $10K |
| 81025 | <1% | 5,267 | $9K | |
| 0720 | <1% | 184 | $9K | |
| 83880 | <1% | 1,885 | $9K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,248 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 370 | $8K |
| 83735 | <1% | 2,496 | $8K | |
| 84484 | <1% | 4,755 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 262 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 542 | $7K |
| 99070 | <1% | 416 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,450 | $7K |
| 12002 | <1% | 39 | $7K | |
| 71250 | <1% | 16 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,996 | $7K |
| 83690 | <1% | 5,479 | $6K | |
| 72072 | <1% | 106 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 226 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 531 | $6K |
| 96367 | <1% | 114 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 106 | $5K |
| 96376 | <1% | 1,006 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,903 | $5K |
| 85027 | <1% | 3,517 | $5K | |
| 72040 | <1% | 80 | $5K | |
| 76536 | <1% | 37 | $4K | |
| 87040 | <1% | 2,277 | $4K | |
| 72110 | <1% | 32 | $4K | |
| 0760 | <1% | 86 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,361 | $4K |
| 76642 | <1% | 26 | $3K | |
| 90715 | <1% | 538 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 360 | $3K |
| 12011 | <1% | 12 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 162 | $3K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 99 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 799 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 249 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 463 | $3K |
| 0011A | <1% | 64 | $3K | |
| 87147 | <1% | 303 | $2K | |
| 73100 | <1% | 54 | $2K | |
| A9270 | Non-covered item or service | <1% | 1,094 | $2K |
| 0012A | <1% | 55 | $2K | |
| 85610 | <1% | 1,843 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $2K |
| 87070 | <1% | 26 | $2K | |
| 73590 | <1% | 55 | $2K | |
| 72050 | <1% | 27 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,477 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 638 | $2K |
| 76770 | <1% | 27 | $1K | |
| 84145 | <1% | 391 | $1K | |
| 86901 | <1% | 597 | $1K | |
| 87186 | <1% | 890 | $1K | |
| 73090 | <1% | 15 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 44 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 767 | $1K |
| 97165 | <1% | 15 | $940.26 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 305 | $935.86 |
| 86141 | <1% | 199 | $933.61 | |
| 85379 | <1% | 714 | $822.38 | |
| 59025 | Fetal non-stress test | <1% | 93 | $798.21 |
| 86885 | <1% | 202 | $797.07 | |
| 74019 | <1% | 15 | $774.57 | |
| J2704 | Injection, propofol, 10 mg | <1% | 84 | $718.81 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 523 | $701.88 |
| 85730 | <1% | 310 | $655.76 | |
| 86900 | <1% | 308 | $630.52 | |
| 0761 | <1% | 14 | $576.29 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 114 | $552.93 |
| S0028 | Injection, famotidine, 20 mg | <1% | 94 | $514.50 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 46 | $500.20 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 87 | $446.96 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 82 | $446.25 |
| Z7500 | <1% | 13 | $443.30 | |
| 76801 | <1% | 30 | $400.72 | |
| 0272 | <1% | 145 | $272.96 | |
| 84702 | <1% | 469 | $271.82 | |
| 85007 | <1% | 358 | $221.37 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 44 | $198.17 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $101.86 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $83.23 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 47 | $81.61 |
| 82550 | <1% | 15 | $67.74 | |
| 99406 | <1% | 401 | $54.44 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 83 | $53.50 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 17 | $31.89 |
| 86880 | <1% | 17 | $25.70 | |
| 84439 | <1% | 14 | $23.69 | |
| 84100 | <1% | 20 | $14.48 | |
| 85651 | <1% | 15 | $14.32 | |
| 87205 | 0% | 12 | $0.00 | |
| 0636 | 0% | 16 | $0.00 | |
| 0271 | 0% | 14 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCANADY, CAROLYN (CHIEF FINANCIAL OFFICER)
Parent organizationSIERRA NEVADA MEMORIAL-MINERS HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Sierra Nevada Memorial-Miners Hospital | Grass Valley, CA | $44K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.